Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication

被引：75
作者：
Bosch, JL
Hunink, MGM
机构：
[1] Massachusetts Gen Hosp, Dept Radiol, HMS, Boston, MA 02114 USA
[2] Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[3] Erasmus Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands
[4] Harvard Univ, Sch Publ Hlth, Harvard Ctr Risk Anal, Boston, MA 02115 USA
来源：
QUALITY OF LIFE RESEARCH | 2000年 / 9卷 / 06期
关键词：
EuroQol EQ-5D (EQ-5D); health-related quality-of-life; Health Utilities Index (HUI); intermittent claudication; randomized controlled trial; rating scale; SF-36; standard gamble; time tradeoff;
D O I：
10.1023/A:1008929129537
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
The Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D (EQ-5D) were compared to each other and to other quality-of-life (QoL) measures in patients treated for intermittent claudication. A total of 88 patients with intermittent claudication completed the HUI3, EQ-5D, RAND 36-Item Health Survey 1.0, time tradeoff, standard gamble, and rating scale before revascularization and at follow-up at 1 month, 3 months, and 1 year. The effect of treatment on the HUI3 and EQ-5D dimensions and the overall scores, calculated using published formulas based on societal preferences, were compared. After 1 month of treatment, the majority of patients showed improvement on the HUI3 dimensions ambulation and pain and on the EQ-5D dimensions mobility, usual activities, and pain/discomfort. The mean HUI3 score was significantly higher than the mean EQ-5D score (0.66 and 0.57, respectively, p < 0.01) before treatment. After treatment, however, they were not significantly different from each other (e.g., 12 months after treatment: 0.77 and 0.75, respectively (p > 0.05). After 1 month, the scores did not change significantly over time (p > 0.05). The intraclass correlation coefficient between changes over time in the HUI3 and EQ-5D scores was 0.30, with other health-related quality-of-life (HRQoL) measures the correlations for HUI3 and EQ-5D were very similar. In conclusion, both the HUI3 and EQ-5D demonstrated an effect of treatment in patients with intermittent claudication; in addition, they showed similar relationships with other (HRQoL) measures. To demonstrate the effect of revascularization in patients with intermittent claudication, however, clinicians and researchers should be aware of the differences in the mean HUI3 and EQ-5D scores.
引用
收藏
页码：591 / 601
页数：11
相关论文
共 50 条
[41]   Health-related quality of life in injury patients: the added value of extending the EQ-5D-3L with a cognitive dimension [J].
Ophuis, Robbin H. ;
Janssen, Mathieu F. ;
Bonsel, Gouke J. ;
Panneman, Martien J. ;
Polinder, Suzanne ;
Haagsma, Juanita A. .
QUALITY OF LIFE RESEARCH, 2019, 28 (07) :1941-1949
[42]   Health-related quality of life in injury patients: the added value of extending the EQ-5D-3L with a cognitive dimension [J].
Robbin H. Ophuis ;
Mathieu F. Janssen ;
Gouke J. Bonsel ;
Martien J. Panneman ;
Suzanne Polinder ;
Juanita A. Haagsma .
Quality of Life Research, 2019, 28 :1941-1949
[43]   Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial [J].
T. Shiroiwa ;
T. Fukuda ;
K. Shimozuma ;
M. Mouri ;
Y. Hagiwara ;
H. Doihara ;
H. Akabane ;
M. Kashiwaba ;
T. Watanabe ;
Y. Ohashi ;
H. Mukai .
Quality of Life Research, 2017, 26 :445-453
[44]   Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial [J].
Shiroiwa, T. ;
Fukuda, T. ;
Shimozuma, K. ;
Mouri, M. ;
Hagiwara, Y. ;
Doihara, H. ;
Akabane, H. ;
Kashiwaba, M. ;
Watanabe, T. ;
Ohashi, Y. ;
Mukai, H. .
QUALITY OF LIFE RESEARCH, 2017, 26 (02) :445-453
[45]   Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3L: a comparison of the 2008 and 2013 National Health Services Surveys [J].
Yao, Qiang ;
Liu, Chaojie ;
Zhang, Yaoguang ;
Xu, Ling .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2019, 17 (1)
[46]   Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3 L: a comparison of the 2008 and 2013 National Health Services Surveys [J].
Qiang Yao ;
Chaojie Liu ;
Yaoguang Zhang ;
Ling Xu .
Health and Quality of Life Outcomes, 17
[47]   Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State [J].
Hua, Nicole ;
Gomez, Alvaro ;
Lindblom, Julius ;
Emamikia, Sharzad ;
Enman, Yvonne ;
Grannas, David ;
Heintz, Emelie ;
Regardt, Malin ;
Parodis, Ioannis .
RHEUMATOLOGY, 2023, 62 (12) :3916-3923
[48]   Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample: A Finite Mixture Approach [J].
Perraillon, Marcelo Coca ;
Shih, Ya-Chen Tina ;
Thisted, Ronald A. .
MEDICAL DECISION MAKING, 2015, 35 (07) :888-901
[49]   The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5D [J].
Tutein Nolthenius, Joanne B. ;
Griffiths, Annabel ;
Dodd, Olivia ;
Wyn, Robin ;
Enstone, Ashley ;
Whalen, John .
ADVANCES IN THERAPY, 2025,
[50]   Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states [J].
Lipman, S. A. ;
Reckers-Droog, V. T. ;
Karimi, M. ;
Jakubczyk, M. ;
Attema, A. E. .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2021, 22 (09) :1507-1518
12345